1. Home
  2. LUNR vs ANAB Comparison

LUNR vs ANAB Comparison

Compare LUNR & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intuitive Machines Inc.

LUNR

Intuitive Machines Inc.

N/A

Current Price

$10.62

Market Cap

1.7B

Sector

Industrials

ML Signal

N/A

Logo AnaptysBio Inc.

ANAB

AnaptysBio Inc.

N/A

Current Price

$48.45

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LUNR
ANAB
Founded
2013
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
LUNR
ANAB
Price
$10.62
$48.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
8
Target Price
$29.00
★ $87.25
AVG Volume (30 Days)
★ 6.7M
465.6K
Earning Date
11-12-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
84.23
★ 91.02
EPS
★ N/A
N/A
Revenue
$210,059,000.00
★ $234,603,000.00
Revenue This Year
$337.87
N/A
Revenue Next Year
$26.94
$69.42
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 157.01
52 Week Low
$7.78
$30.27
52 Week High
$46.75
$73.30

Technical Indicators

Market Signals
Indicator
LUNR
ANAB
Relative Strength Index (RSI) 36.39 46.60
Support Level $10.04 $44.38
Resistance Level $16.15 $51.94
Average True Range (ATR) 0.78 2.32
MACD 0.08 0.47
Stochastic Oscillator 21.40 53.73

Price Performance

Historical Comparison
LUNR
ANAB

About LUNR Intuitive Machines Inc.

Intuitive Machines Inc is a space infrastructure and services company focused on enabling sustained human activity beyond Earth. It designs, builds, integrates, and operates space systems, offering infrastructure-as-a-service across low Earth orbit, geostationary orbit, cislunar space, and deep space. Its capabilities include spacecraft development and space-based network connectivity, serving commercial, civil, and national security customers. The company conducts sales both directly and through an extensive customer and partner network spanning North America, South America, Europe, Asia, and Australia, including rideshare delivery providers, lunar surface mobility providers, payload providers, communication satellite providers, and ground segment providers.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: